These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 37499554

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Opioid overdoses involving xylazine in emergency department patients: a multicenter study.
    Love JS, Levine M, Aldy K, Brent J, Krotulski AJ, Logan BK, Vargas-Torres C, Walton SE, Amaducci A, Calello D, Hendrickson R, Hughes A, Kurt A, Judge B, Pizon A, Schwarz E, Shulman J, Wiegan T, Wax P, Manini AF.
    Clin Toxicol (Phila); 2023 Mar; 61(3):173-180. PubMed ID: 37014353
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Xylazine-involved fatal overdoses and localized geographic clustering: Cook County, IL, 2019-2022.
    Delcher C, Anthony N, Mir M.
    Drug Alcohol Depend; 2023 Aug 01; 249():110833. PubMed ID: 37352735
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings.
    Perrone J, Haroz R, D'Orazio J, Gianotti G, Love J, Salzman M, Lowenstein M, Thakrar A, Klipp S, Rae L, Reed MK, Sisco E, Wightman R, Nelson LS.
    Ann Emerg Med; 2024 Jul 01; 84(1):20-28. PubMed ID: 38493376
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Barriers to, and Facilitators of, Checking Drugs for Adulterants in the Era of Fentanyl and Xylazine: Qualitative Study.
    Aronson ID, Ardouin-Guerrier MA, Baus JE, Bennett AS.
    JMIR Form Res; 2024 Jul 03; 8():e56755. PubMed ID: 38959505
    [Abstract] [Full Text] [Related]

  • 11. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
    Carroll JJ, Marshall BDL, Rich JD, Green TC.
    Int J Drug Policy; 2017 Aug 03; 46():136-145. PubMed ID: 28578864
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review.
    Zhu DT.
    Harm Reduct J; 2023 Sep 12; 20(1):131. PubMed ID: 37700329
    [Abstract] [Full Text] [Related]

  • 19. The discounting of death: Probability discounting of heroin use by fatal overdose likelihood and drug purity.
    Dolan SB, Johnson MW, Dunn KE, Huhn AS.
    Exp Clin Psychopharmacol; 2021 Jun 12; 29(3):219-228. PubMed ID: 34264734
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.